Bedaquiline fumarate microemulsion: formulation optimization, rheological characterization and in vitro studies

Nanomedicine (Lond). 2022 Sep;17(21):1529-1546. doi: 10.2217/nnm-2022-0132. Epub 2022 Nov 23.

Abstract

Aim: Bedaquiline fumarate (BQF), an antitubercular drug, shows limited bioavailability due to solubility-limited intestinal absorption. In this research, the authors formulated a BQF-loaded microemulsion to improve BQF's oral bioavailability. Methods: Microemulsion was prepared by a spontaneous emulsification method and evaluated for thermodynamic stability, size, dispersibility, transmittance, rheology, microrheology, drug release, cytotoxicity and cellular uptake. Results: Microemulsion showed an average globule size of 26.50 ± 6.29 nm with spherical geometry and revealed gel-sol-gel behavior in microrheological studies. Cytotoxicity and cell uptake studies in Caco-2 cells showed that BQF microemulsion was cytocompatible at the highest concentration of 500 μg/ml with significantly higher cellular uptake than control. Conclusion: The present study indicates that BQF microemulsion could be explored further for effective treatment of multidrug-resistant tuberculosis.

Keywords: bedaquiline fumarate; bioavailability enhancement; cellular uptake; cytotoxicity; microemulsion; rheology; tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Availability
  • Caco-2 Cells
  • Emulsions
  • Humans
  • Particle Size
  • Rheology
  • Solubility
  • Surface-Active Agents*

Substances

  • bedaquiline
  • Surface-Active Agents
  • Emulsions